Literature DB >> 31609493

Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon.

Leonardo Zorron Cheng Tao Pu1,2, Kenta Yamamoto2, Takashi Honda2, Masanao Nakamura2, Takeshi Yamamura3, Shun Hattori2, Alastair D Burt1, Rajvinder Singh1,4, Yoshiki Hirooka5, Mitsuhiro Fujishiro2.   

Abstract

BACKGROUND AND AIM: Microbiota have been associated with several diseases including colorectal cancer (CRC). This study aimed to evaluate the microbiota in early/invasive CRC utilizing stool and cytological brushes to determine differences in relative abundance (RA).
METHODS: Colonoscopy patients referred for endoscopic submucosal dissection or previous to CRC surgery were prospectively enrolled. Stool was collected pre-bowel preparation; and brush samples were taken during colonoscopy (three regions). DNA extraction, 16S rRNA next generation sequencing, and biostatistics (qiime and stamp software packages) followed. Primary outcome was the difference in RA of the Fusobacterium genus between the groups. Secondary outcomes included analyses of other microbiota.
RESULTS: Twenty-five patients were included, of which 14 had invasive cancer (≥ 1000 mm into the submucosa). The three major genera for invasive cancer were Bacterioides, Oribacterium, and Fusobacterium, whereas for early cancer were Oribacterium, Bacterioides, and Prevotella (decreasing order of RA). There was a significantly higher RA of Fusobacterium in the invasive cancer group (9.65% vs 0.95%, respectively, P < 0.001). The RA of all genera was similar throughout the colon. In addition to Fusobacterium, the genera Corynebacterium, Enterococcus, Neisseria, Porphyromonas, and Sclegelella showed statistically higher RA in the invasive cancer group. Conversely, the genera Oribacterium, Desulfovibrio, Clostridiales, and Lactobacillus showed lower RA in the invasive cancer group.
CONCLUSIONS: The RA of Fusobacterium is higher with invasive CRC than in early CRC patients. In addition, five other bacteria genera were found to be increased, and four decreased in invasive CRC patients. The microbiota per patient was similar throughout the colon.
© 2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Fusobacterium nucleatum; colonoscopy; colorectal neoplasms; gastrointestinal microbiome; microbiota

Year:  2019        PMID: 31609493     DOI: 10.1111/jgh.14868

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  Preliminary Comparison of Endoscopic Brush and Net Catheters as the Sampling Tool to Analyze the Intestinal Mucus in the Rectum with Ulcerative Colitis Patients.

Authors:  Masanao Nakamura; Keiko Maeda; Kenta Yamamoto; Takeshi Yamamura; Tsunaki Sawada; Eri Ishikawa; Naomi Kakushima; Kazuhiro Furukawa; Tadashi Iida; Yasuyuki Mizutani; Takuya Ishikawa; Eizaburo Ohno; Takashi Honda; Masatoshi Ishigami; Hiroki Kawashima
Journal:  Digestion       Date:  2022-02-18       Impact factor: 3.672

2.  Different dietary starch patterns in low-protein diets: effect on nitrogen efficiency, nutrient metabolism, and intestinal flora in growing pigs.

Authors:  Junyan Zhou; Lu Wang; Lijie Yang; Guangxin Yang; Xiangfang Zeng; Shiyan Qiao
Journal:  J Anim Sci Biotechnol       Date:  2022-06-02

3.  Benchmarking of 16S rRNA gene databases using known strain sequences.

Authors:  Kunal Dixit; Dimple Davray; Diptaraj Chaudhari; Pratik Kadam; Rudresh Kshirsagar; Yogesh Shouche; Dhiraj Dhotre; Sunil D Saroj
Journal:  Bioinformation       Date:  2021-03-31

Review 4.  Microbes in Tumoral In Situ Tissues and in Tumorigenesis.

Authors:  Xue Feng; Lu Han; Sijia Ma; Lanbo Zhao; Lei Wang; Kailu Zhang; Panyue Yin; Lin Guo; Wei Jing; Qiling Li
Journal:  Front Cell Infect Microbiol       Date:  2020-11-24       Impact factor: 5.293

5.  Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.

Authors:  Thyra Löwenmark; Anna Löfgren-Burström; Carl Zingmark; Vincy Eklöf; Michael Dahlberg; Sun Nyunt Wai; Pär Larsson; Ingrid Ljuslinder; Sofia Edin; Richard Palmqvist
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

6.  Intestinal microbiota profiles in a genetic model of colon tumorigenesis correlates with colon cancer biomarkers.

Authors:  Francesco Vitali; Katia Tortora; Monica Di Paola; Gianluca Bartolucci; Marta Menicatti; Carlotta De Filippo; Giovanna Caderni
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

7.  Albuca Bracteata Polysaccharides Attenuate AOM/DSS Induced Colon Tumorigenesis via Regulating Oxidative Stress, Inflammation and Gut Microbiota in Mice.

Authors:  Ziyan Qin; Xinyu Yuan; Jian Liu; Zhuqing Shi; Leipeng Cao; Lexuan Yang; Kai Wu; Yongliang Lou; Haibin Tong; Lei Jiang; Jimei Du
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

8.  Clinical significance and intestinal microbiota composition in immunocompromised children with norovirus gastroenteritis.

Authors:  Pei-Chun Lin; Yu-Chen S H Yang; Sheng-Chieh Lin; Meng-Che Lu; Yin-Tai Tsai; Shou-Cheng Lu; Shu-Huey Chen; Shih-Yen Chen
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.752

Review 9.  Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression.

Authors:  Edgar Torres-Maravilla; Anne-Sophie Boucard; Amir Hossein Mohseni; Sedigheh Taghinezhad-S; Naima G Cortes-Perez; Luis G Bermúdez-Humarán
Journal:  Microorganisms       Date:  2021-05-10

10.  Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.

Authors:  Justin Chau; Meeta Yadav; Ben Liu; Muhammad Furqan; Qun Dai; Shailesh Shahi; Arnav Gupta; Keri Nace Mercer; Evan Eastman; Taher Abu Hejleh; Carlos Chan; George J Weiner; Catherine Cherwin; Sonny T M Lee; Cuncong Zhong; Ashutosh Mangalam; Jun Zhang
Journal:  BMC Cancer       Date:  2021-07-13       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.